VEGFR-2-specific ligand VEGF-E induces non-edematous hyper-vascularization in mice

Biochemical and Biophysical Research Communications

Volumn 301, Issue 2, 2003, Pages 371-377

  Kiba, Atsushi ^a   Sagara, Hiroshi ^a   Hara, Takeshi ^a   Shibuya, Masabumi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Angiogenic factor; K14 transgenic mice; PlGF; Side effects; VEGF E; VEGFR 2

Indexed keywords

KERATIN; LIGAND; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN E; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAPILLARY; CONTROLLED STUDY; DRUG USE; EDEMA; MICROSCOPY; MOUSE; NONHUMAN; PERICYTE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; SKIN BLEEDING; SUBCUTANEOUS TISSUE; TRANSGENIC MOUSE; VASCULARIZATION;

MUS MUSCULUS;

EID: 0037423716     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)03033-4     Document Type: Article

References (31)

1. Ferrara N., Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr. Rev. 18:1997;4-25.
2. Folkman J., D'Amore P.A. Blood vessel formation: what is its molecular basis? Cell. 87:1996;1153-1155.
3. Shibuya M., Ito N., Claesson-Welsh L. Structure and function of VEGF Receptor-1 and -2. Curr. Topics Microbiol. Immunol. 237:1999;59-83.
4. Leung D.W., Cachianes G., Kuang W.J., Goeddel D.V., Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 246:1989;1306-1309.
5. Senger D.R., Galli S.J., Dvorak A.M., Perruzzi C.A., Harvey V.S., Dvorak H.F. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science. 219:1983;983-985.
6. Shibuya M., Yamaguchi S., Yamane A., Ikeda T., Tojo A., Matsushime H., Sato M. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene. 5:1990;519-524.
7. De Vries C., Escobedo J.A., Ueno H., Houck K., Ferrara N., Williams L.T. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science. 255:1992;989-991.
8. Terman B.I., Dougher-Vermazen M., Carrion M.E., Dimitrov D., Armellino D.C., Gospodarowicz D., Bohlen P. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem. Biophys. Res. Commun. 187:1992;1579-1586.
9. Quinn T.P., Peters K.G., De Vries C., Ferrara N., Williams L.T. Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc. Natl. Acad. Sci. USA. 90:1993;7533-7537.
10. Matthews W., Jordan C.T., Wiegand G.W., Pardoll D., Lemischka I.R. A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit. Proc. Natl. Acad. Sci. USA. 88:1991;9026-9030.
11. Shalaby F., Rossant J., Yamaguchi T.P., Gertsenstein M., Wu X.-F., Breitman M.L., Schuh A.C. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature. 376:1995;62-66.
12. Fong G.H., Rossant J., Gertsenstein M., Breitman M.L. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature. 376:1995;66-70.
13. Waltenberger J., Claesson-Welsh L., Siegbahn A., Shibuya M., Heldin C.-H. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J. Biol. Chem. 269:1994;26988-26995.
14. Keyt B.A., Nguyen H.V., Berleau L.T., Duarte C.M., Park J., Chen H., Ferrara N. Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis. J. Biol. Chem. 271:1996;5638-5646.
15. Takahashi T., Yamaguchi S., Chida K., Shibuya M. A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-. γ and DNA synthesis in vascular endothelial cells EMBO J. 20:2001;2768-2778.
16. Seetharam L., Gotoh N., Maru Y., Neufeld G., Yamaguchi S., Shibuya M. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF. Oncogene. 10:1995;135-147.
17. Sawano A., Takahashi T., Yamaguchi S., Aonuma T., Shibuya M. Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor. Cell Growth Differ. 7:1996;213-221.
18. Ogawa S., Oku A., Sawano A., Yamaguchi S., Yazaki Y., Shibuya M. A novel type of vascular endothelial growth factor, VEGF-E (NZ-7 VEGF), preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain. J. Biol. Chem. 273:1998;31273-31282.
19. Lyttle D.J., Fraser K.M., Fleming S.B., Mercer A.A., Robinson A.J. Homologs of vascular endothelial growth factor are encoded by the poxvirus orf virus. J. Virol. 68:1994;84-92.
20. Cottone R., Buttner M., Bauer B., Henkel M., Hettich E., Rziha H.J. Analysis of genomic rearrangement and subsequent gene deletion of the attenuated Orf virus strain D1701. Virus Res. 56:1998;53-67.
21. Meyer M., Clauss M., Lepple-Wienhues A., Waltenberger J.et al. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases. EMBO J. 18:1999;363-374.
22. Wise L.M., Veikkola T., Mercer A.A., Savory L.J.et al. Vascular endothelial growth factor (VEGF)-like protein from orf virus NZ2 binds to VEGFR2 and neuropilin-1. Proc. Natl. Acad. Sci. USA. 96:1999;3071-3076.
23. Rziha H.J., Henkel M., Cottone R., Meyer M., Dehio C., Buttner M. Parapoxviruses: potential alternative vectors for directing the immune response in permissive and non-permissive hosts. J. Biotechnol. 73:1999;235-242.
24. Vassar R., Rosenberg M., Ross S., Tyner A., Fuchs E. Tissue-specific and differentiation-specific expression of a human K14 keratin gene in transgenic mice. Proc. Natl. Acad. Sci. USA. 86:1989;1563-1567.
25. Detmar M., Brown L.F., Schon M.P., Elicker B.M.et al. Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J. Invest. Dermatol. 111:1998;1-6.
26. Larcher F., Murillas R., Bolontrade M., Conti C.J., Jorcano J.L. VEGF/VPF overexpression in skin of transgenic mice induces angiogenesis, vascular hyperpermeability and accelerated tumor development. Oncogene. 17:1998;303-311.
27. Thurston G., Suri C., Smith K., McClain J., Sato T.N., Yancopoulos G.D., McDonald D.M. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science. 286:1999;2511-2514.
28. Oh S.P., Seki T., Goss K.A., Imamura T., Yi Y., Donahoe P.K., Li L., Miyazono K., Dijke P., Kim S., Li E. Activin receptor-like kinase 1 modulates transforming growth factor-1 signaling in the regulation of angiogenesis. Proc. Natl. Acad. Sci. USA. 97:2000;2626-2631.
29. Takakura N., Huang X.L., Naruse T., Hamaguchi I., Dumont D.J., Yancopoulos G.D., Suda T. Critical role of the TIE2 endothelial cell receptor in the development of definitive hematopoiesis. Immunity. 9:1998;677-686.
30. Murakami T., Fujita T., Hinenoya H. A modified method for vascular casting and scanning electron microscopy: its utility in the demonstration of rat pancreatic insulo-acinar and other blood vascular systems. Arch. Histol. Cytol. 55:1992;233-238.
31. Patan S., Alvarez M.J., Schittny J.C., Burri P.H. Intussusceptive microvascular growth: a common alternative to capillary sprouting. Arch. Histol. Cytol. 55:1992;65-75.